vs
Side-by-side financial comparison of Axogen, Inc. (AXGN) and Integer Holdings Corp (ITGR). Click either name above to swap in a different company.
Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering (IPO). Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is...
Integer Holdings Corp is a global medical device contract manufacturing partner for leading healthcare and medtech enterprises. It designs, develops and produces high-precision components, assemblies and finished medical devices across core segments including cardiac care, neuromodulation, orthopedics and portable medical products, serving markets across North America, Europe and Asia-Pacific.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $59.9M | — | ||
| Q3 25 | $60.1M | — | ||
| Q2 25 | $56.7M | — | ||
| Q1 25 | $48.6M | — | ||
| Q4 24 | $49.4M | — | ||
| Q3 24 | $48.6M | — | ||
| Q2 24 | $47.9M | — | ||
| Q1 24 | $41.4M | — |
| Q4 25 | $-13.2M | — | ||
| Q3 25 | $708.0K | — | ||
| Q2 25 | $579.0K | — | ||
| Q1 25 | $-3.8M | — | ||
| Q4 24 | $450.0K | — | ||
| Q3 24 | $-1.9M | — | ||
| Q2 24 | $-1.9M | — | ||
| Q1 24 | $-6.6M | — |
| Q4 25 | 74.1% | — | ||
| Q3 25 | 76.6% | — | ||
| Q2 25 | 74.2% | — | ||
| Q1 25 | 71.9% | — | ||
| Q4 24 | 76.1% | — | ||
| Q3 24 | 74.9% | — | ||
| Q2 24 | 73.8% | — | ||
| Q1 24 | 78.8% | — |
| Q4 25 | -16.3% | — | ||
| Q3 25 | 3.2% | — | ||
| Q2 25 | 3.0% | — | ||
| Q1 25 | -3.4% | — | ||
| Q4 24 | 4.1% | — | ||
| Q3 24 | -0.6% | — | ||
| Q2 24 | -0.9% | — | ||
| Q1 24 | -11.0% | — |
| Q4 25 | -22.0% | — | ||
| Q3 25 | 1.2% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | -7.9% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | -3.8% | — | ||
| Q2 24 | -4.0% | — | ||
| Q1 24 | -16.0% | — |
| Q4 25 | $-0.28 | — | ||
| Q3 25 | $0.01 | — | ||
| Q2 25 | $0.01 | — | ||
| Q1 25 | $-0.08 | — | ||
| Q4 24 | $-0.00 | — | ||
| Q3 24 | $-0.04 | — | ||
| Q2 24 | $-0.04 | — | ||
| Q1 24 | $-0.15 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
